News - Zhongshan Wanhan Pharmaceuticals Co., Ltd

WANHAN PHARMACEUTICAL COMPANY丨API Epalrestat has been successfully authorized.
WANHAN PHARMACEUTICAL COMPANY丨API Bumetanide has been successfully authorized.
Wanhan Pharmaceutical Company 丨 Visit us at Booth 711 International Exhibition of Pharmaceuticals, Engineering and Biotechnology
WANHAN PHARMACEUTICAL COMPANY: Vortioxetine Hydrobromide Tablets has been successfully approved.
WANHAN PHARMACEUTICAL COMPANY: Join us at the Xiding Conference in Huzhou, March 14-18!
Holiday Notice | Wanhan Pharmaceutical Company sends warm greetings and best wishes for a Happy Chinese New Year!
Congratulations to the approval of API Norepinephrine Bitartrate!
Wanhan Pharmaceutical Company 丨 visit us at booth No.6 in the 18th Annual Meeting of the Chinese Physicians Association of Ophthalmology

Contact Us

Foreign Trade Email：

Foreign-Trade@whpt.com.cn

Foreign-Trade1@whpt.com.cn

Foreign Trade：

+86 139-2498-2439 (WhatsApp，WeChat)
+86 189-8859-3463
+86 199-2800-9162

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.